Changes and challenges of surgical treatment strategy for hepatocellular carcinoma
10.3760/cma.j.cn112139-20201209-00849
- VernacularTitle:肝癌外科治疗策略的转变与挑战
- Author:
Tianqiang SONG
1
Author Information
1. 国家肿瘤临床医学研究中心 天津医科大学肿瘤医院肝癌防治研究中心肝胆肿瘤科 300060
- Keywords:
Liver neoplasms;
Surgical procedures,operative;
Neoadjuvant therapy
- From:
Chinese Journal of Surgery
2021;59(6):447-451
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma(HCC) is a common malignant tumor with high morbidity and mortality in China and even in the world.Due to its tumor heterogeneity and dissemination and distant metastasis,prognosis of patients with HCC is often poor.Surgical treatment such as radical hepatectomy is still the first choice for patients with HCC in the current clinical practice.However,the high recurrence and metastasis rate after surgery still hinder the survival and prognosis of these patients.In the era of target and immunotherapy,changes of surgical treatment strategy for HCC is particularly critical.This review focuses on the definition,the feasibility and the evaluation criteria of neoadjuvant therapy for HCC,to provide a new perspective on surgical treatment for HCC.
